Pheast Therapeutics
PALO ALTO, CA · Biotechnology · 39 employees
Pheast Therapeutics is a cancer immunotherapy company focused on developing novel checkpoint therapies to harness the innate immune system in the fight against cancer.
Funding history
- Funding Round — $24.6M — Oct 2025
- Funding Round — $75.3M — Apr 2025
- Funding Round — $75.3M — Oct 2022
Recent signals
- Oct 16, 2025: Raised $24.6M
- Apr 10, 2025: Raised $75.3M
- Oct 28, 2022: Raised $75.3M
See plans & pricing → Track Pheast Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.